Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced its operating results for the first quarter ended March 31, 2015. Revenue and other income for the first quarter ended March 31, 2015 was approximately $142,000, including approximately $127,000 in...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), today announced that Stem World Enterprises, its distributor for East Africa, has been awarded a contract with the Nairobi County Health Services Sector to supply the first LuViva® Advanced Cervical Scan for the...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), developer of a point-of-care and painless testing platform that uses biophotonics for the early detection of disease that leads to cervical cancer, today announced that it is scheduled to report financial results...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), announced today an initiative for procuring provincial-level support for its LuViva Advanced Cervical Scan. The initiative is based on discussions with women’s healthcare experts across Canada, whose interest has...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), announced today it has completed the sale of 4.0 million shares of our common stock and warrants to purchase an additional 2.0 million shares, for an aggregate purchase price of $720,000 in a private placement to...
